University of Occupational and Environmental Health, Japan
Kitakyushu, Japan
Yoshiya Tanaka, M.D., Ph.D. is Professor and Chairman of the First Department of Internal Medicine, School of Medicine (2000-present) and Dean of Graduate School of Medical Science (2017-present), University of Occupational and Environmental Health, Japan. He reviewed 950 publications (impact factor 8,050, h-index 107) in English. His scientific focus lies on pathological analysis and development of novel treatment in systemic autoimmune diseases, rheumatic diseases and endocrine metabolic diseases including osteoporosis. He is a president of Japan College of Rheumatology (JCR) and Japanese Association of Clinical Immunology (JSCI) and was a president of JSBMR; 2013-15. He is a chair of international committee of APLAR and board member of many societies. He is an associate editor of Rheumatology, Cytokine, AR&T, IJRD and many, an editorial board member of ARD, RMD Open, MR, etc. He has received numerous awards from Japanese Society of Inflammation, JSBMR, JCR and EULAR.
15W106: From Genotype to Phenotype: Towards Integration of Genetics and Clinical Medicine
Wednesday, November 15, 2023
8:00 AM – 9:00 AM PT
Disclosure(s): AbbVie: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boehringer-Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chugai: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eisai: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Gilead: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GSK: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Mitsubishi-Tanabe: Grant/Research Support (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Taiho: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Taisho: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
